Literature DB >> 19125109

Lack of exonic sulfotransferase 4A1 mutations in controls and schizophrenia cases.

Aaron G Lewis1, Rodney F Minchin.   

Abstract

Sulfotransferase 4A1 (SULT4A1) is a novel sulfotransferase expressed almost exclusively in the brain. The gene is located on chromosome 22q13.3, a region implicated in predisposition to schizophrenia. Recently, a variable microsatellite region located upstream of SULT4A1 was found to be associated with an increase in schizophrenia risk. We hypothesised that if functional dysregulation of SULT4A1 was involved in the aetiology of schizophrenia, then genetic variants in the coding sequence of SULT4A1 might be identified in cases compared with controls. To test this, we carried out a mutation analysis of the coding region (exons 2-7) in 71 Australian schizophrenia cases and 69 controls. We found no mutations, either synonymous or nonsynonymous, in either cohort. However, intronic variants (IVS5+12 C>T and IVS5+28 G>C) were identified, the frequency of which was not statistically different between cases and controls. The lack of polymorphisms in the coding region of the SULT4A1 gene is highly unusual and, along with its high conservation between species, suggests that SULT4A1 may have an important function in vivo. However, our findings do not support the hypothesis that germline mutations in the coding region of SULT4A1 contribute to susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125109     DOI: 10.1097/YPG.0b013e3283118776

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  5 in total

1.  Sulfotransferase 4A1 Increases Its Expression in Mouse Neurons as They Mature.

Authors:  Takuyu Hashiguchi; Sawako Shindo; Shih-Heng Chen; Jau-Shyong Hong; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2018-04-06       Impact factor: 3.922

2.  Replication of SULT4A1-1 as a pharmacogenetic marker of olanzapine response and evidence of lower weight gain in the high response group.

Authors:  Timothy L Ramsey; Qian Liu; Mark D Brennan
Journal:  Pharmacogenomics       Date:  2014-05       Impact factor: 2.533

Review 3.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

4.  Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.

Authors:  Chun Li; Bangming Pu; Long Gu; Mingwei Zhang; Hongping Shen; Yuan Yuan; Lishang Liao
Journal:  FEBS Open Bio       Date:  2021-02-09       Impact factor: 2.693

5.  Sulfotransferase 4A1 activity facilitates sulfate-dependent cellular protection to oxidative stress.

Authors:  Evan J Brettrager; Arthur W Meehan; Charles N Falany; Robert C A M van Waardenburg
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.